id | C00005413 |
---|---|
Name | Rutin / Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside |
CAS RN | 153-18-4 |
Standard InChI | InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8?,15?,17-,18+,20-,21?,22?,23?,26+,27-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3 |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 1 |
By standard InChI | |
---|---|
By standard InChI Main Layer | CHEMBL32579 CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
By LinkDB | C05625 |
---|
By CAS RN | D012431 |
---|
class name | count |
---|---|
rosids | 43 |
asterids | 39 |
eudicotyledons | 7 |
Magnoliophyta | 3 |
Spermatophyta | 2 |
Liliopsida | 1 |
family name | count |
---|---|
Asteraceae | 15 |
Fabaceae | 14 |
Euphorbiaceae | 6 |
Rosaceae | 4 |
Polygonaceae | 4 |
Lamiaceae | 4 |
Moraceae | 3 |
Oleaceae | 3 |
Araliaceae | 3 |
Solanaceae | 3 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL226335 |
CHEMBL2045961
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL226335 |
CHEMBL1014033
(1)
|
0 / 3 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL226335 |
CHEMBL1614079
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL226335 |
CHEMBL1614076
(1)
|
1 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL226335 |
CHEMBL1023248
(1)
|
1 / 1 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL226335 |
CHEMBL1120976
(1)
|
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL226335 |
CHEMBL1614166
(1)
CHEMBL1738096
(1)
CHEMBL1738622 (1) |
1 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL226335 |
CHEMBL1014691
(1)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL226335 |
CHEMBL1120977
(1)
|
0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | CHEMBL502782 |
CHEMBL974554
(1)
|
0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1532989 |
CHEMBL1794467
(1)
|
0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | CHEMBL226335 |
CHEMBL814346
(1)
|
4 / 2 |
P06276 | Cholinesterase | Hydrolase | CHEMBL226335 |
CHEMBL1045780
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL226335 |
CHEMBL1614521
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1436093 |
CHEMBL1614227
(1)
|
3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL226335 |
CHEMBL2045959
(1)
CHEMBL2045960
(1)
|
2 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL226335 |
CHEMBL999944
(1)
CHEMBL1941568
(1)
CHEMBL1941569 (1) |
1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL226335 |
CHEMBL1045781
(1)
|
1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL32579 CHEMBL226335 |
CHEMBL972070
(1)
CHEMBL1614108
(1)
CHEMBL1613886 (1) |
0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL32579 CHEMBL226335 |
CHEMBL1614211
(2)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL32579 CHEMBL226335 |
CHEMBL1614421
(2)
|
4 / 3 |
P48147 | Prolyl endopeptidase | S9A | CHEMBL502782 |
CHEMBL974553
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL32579 CHEMBL226335 CHEMBL1532989 |
CHEMBL1794536
(3)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL32579 CHEMBL226335 CHEMBL1532989 |
CHEMBL1613914
(3)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL226335 |
CHEMBL1738442
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D012431 | 177 |
AGER
RAGE |
advanced glycosylation end product-specific receptor | Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D012431 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Rutin promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased localization of AHR protein] |
increases localization
/ increases reaction |
protein |
21756928
|
D012431 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Rutin results in decreased localization of AHR protein |
decreases localization
|
protein |
21756928
|
D012431 | 405 |
ARNT
HIF-1-beta HIF-1beta HIF1-beta HIF1B HIF1BETA TANGO bHLHe2 |
aryl hydrocarbon receptor nuclear translocator | Rutin results in increased localization of ARNT protein |
increases localization
|
protein |
21756928
|
D012431 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Rutin affects the expression of BAX protein |
affects expression
|
protein |
15975156
|
D012431 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Rutin affects the expression of BCL2 protein |
affects expression
|
protein |
15975156
|
D012431 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D012431 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Rutin affects the cleavage of CASP3 protein |
affects cleavage
|
protein |
15975156
|
D012431 | 847 |
CAT
|
catalase (EC:1.11.1.6) | Rutin inhibits the reaction [bifenthrin results in decreased activity of CAT protein] |
decreases activity
/ decreases reaction |
protein |
19833193
|
D012431 | 873 |
CBR1
CBR SDR21C1 hCBR1 |
carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) | Rutin binds to and results in decreased activity of CBR1 protein |
affects binding
/ decreases activity |
protein |
18579125
|
D012431 | 873 |
CBR1
CBR SDR21C1 hCBR1 |
carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) | Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] |
decreases reaction
/ increases metabolic processing |
protein |
11306090
|
D012431 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21756928
|
D012431 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Rutin results in decreased expression of CCL2 mRNA |
decreases expression
|
mRNA |
21756928
21967610 |
D012431 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Rutin results in decreased secretion of CCL2 protein |
decreases secretion
|
protein |
21967610
|
D012431 | 3627 |
CXCL10
C7 IFI10 INP10 IP-10 SCYB10 crg-2 gIP-10 mob-1 |
chemokine (C-X-C motif) ligand 10 | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 3627 |
CXCL10
C7 IFI10 INP10 IP-10 SCYB10 crg-2 gIP-10 mob-1 |
chemokine (C-X-C motif) ligand 10 | Rutin results in decreased expression of CXCL10 mRNA |
decreases expression
|
mRNA |
21756928
21967610 |
D012431 | 3627 |
CXCL10
C7 IFI10 INP10 IP-10 SCYB10 crg-2 gIP-10 mob-1 |
chemokine (C-X-C motif) ligand 10 | Rutin results in decreased secretion of CXCL10 protein |
decreases secretion
|
protein |
21756928
21967610 |
D012431 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Rutin results in increased expression of CYP1A1 mRNA |
increases expression
|
mRNA |
21756928
|
D012431 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Rutin results in decreased activity of CYP1B1 protein |
decreases activity
|
protein |
16271822
|
D012431 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein] |
affects localization
/ decreases reaction |
protein |
21967610
|
D012431 | 2936 |
GSR
|
glutathione reductase (EC:1.8.1.7) | Rutin results in decreased activity of GSR protein |
decreases activity
|
protein |
15782287
|
D012431 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 3480 |
IGF1R
CD221 IGFIR IGFR JTK13 |
insulin-like growth factor 1 receptor (EC:2.7.10.1) | Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] |
decreases expression
/ increases response to substance |
protein |
20015448
|
D012431 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D012431 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D012431 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
18958421
|
D012431 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
D012431 | 3569 |
IL6
BSF2 HGF HSF IFNB2 IL-6 |
interleukin 6 (interferon, beta 2) | Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21756928
|
D012431 | 3569 |
IL6
BSF2 HGF HSF IFNB2 IL-6 |
interleukin 6 (interferon, beta 2) | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
18958421
|
D012431 | 3569 |
IL6
BSF2 HGF HSF IFNB2 IL-6 |
interleukin 6 (interferon, beta 2) | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
D012431 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
mRNA |
21756928
|
D012431 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
18958421
|
D012431 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
D012431 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Rutin results in decreased secretion of IL8 protein |
decreases secretion
|
protein |
21756928
21967610 |
D012431 | 3667 |
IRS1
HIRS-1 |
insulin receptor substrate 1 | Rutin results in decreased expression of IRS1 protein |
decreases expression
|
protein |
20015448
|
D012431 | 3667 |
IRS1
HIRS-1 |
insulin receptor substrate 1 | Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein] |
decreases expression
/ increases response to substance |
protein |
20015448
|
D012431 | 3667 |
IRS1
HIRS-1 |
insulin receptor substrate 1 | Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein] |
decreases expression
/ increases response to substance |
protein |
20015448
|
D012431 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Rutin results in decreased expression of JUN protein |
decreases expression
|
protein |
20015448
|
D012431 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein] |
decreases expression
/ increases response to substance |
protein |
20015448
|
D012431 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein] |
decreases expression
/ increases response to substance |
protein |
20015448
|
D012431 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D012431 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Rutin results in decreased phosphorylation of MAPK1 protein |
decreases phosphorylation
|
protein |
21756928
|
D012431 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D012431 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Rutin results in decreased phosphorylation of MAPK3 protein |
decreases phosphorylation
|
protein |
21756928
|
D012431 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D012431 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | [Rutin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTGS2 mRNA |
affects cotreatment
/ decreases expression |
mRNA |
21756928
|
D012431 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D012431 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D012431 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Rutin inhibits the reaction [Glucose affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
19557821
|
D012431 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of RELA protein] |
decreases reaction
/ increases phosphorylation |
protein |
21756928
|
D012431 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 7039 |
TGFA
TFGA |
transforming growth factor, alpha | Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein] |
affects localization
/ decreases reaction |
protein |
21967610
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [Glucose results in increased expression of TNF mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [Glucose results in increased expression of TNF protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] |
affects cotreatment
/ decreases reaction / increases expression |
mRNA |
18958421
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
18958421
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
21756928
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of IL8 protein] |
affects cotreatment
/ decreases reaction / increases secretion |
protein |
21756928
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Rutin results in decreased expression of VEGFA mRNA |
decreases expression
|
mRNA |
20015448
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Rutin results in decreased secretion of and results in decreased expression of VEGFA protein |
decreases expression
/ decreases secretion |
protein |
20015448
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Rutin results in increased susceptibility to [Vitamin E results in decreased expression of VEGFA mRNA] |
decreases expression
/ increases response to substance |
mRNA |
20015448
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Rutin results in increased susceptibility to [Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein] |
decreases expression
/ decreases secretion / increases response to substance |
protein |
20015448
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Vitamin E results in increased susceptibility to [Rutin results in decreased expression of VEGFA mRNA] |
decreases expression
/ increases response to substance |
mRNA |
20015448
|
D012431 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Vitamin E results in increased susceptibility to [Rutin results in decreased secretion of and results in decreased expression of VEGFA protein] |
decreases expression
/ decreases secretion / increases response to substance |
protein |
20015448
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00032 | Thyroid cancer |
P27487
(marker)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D001424 | D012431 | Bacterial Infections |
therapeutic
|
12669766
|
|
D003092 | D012431 | Colitis |
therapeutic
|
15652231
|
|
D004409 | D012431 | Dyskinesia, Drug-Induced |
therapeutic
|
17868205
|
|
D015212 | D012431 | Inflammatory Bowel Diseases |
therapeutic
|
15652231
|
|
D007674 | D012431 | Kidney Diseases |
therapeutic
|
21605616
|
|
D028361 | D012431 | Mitochondrial Diseases |
therapeutic
|
22214982
|
|
D010243 | D012431 | Paralysis |
therapeutic
|
3582421
|
|
D013276 | D012431 | Stomach Ulcer |
therapeutic
|
20374237
|